118 related articles for article (PubMed ID: 10498195)
1. 2,7-diazabicyclo[3.3.0]octanes as novel h5-HT receptor agonists.
Russell MG; Beer MS; Stanton JA; Sohal B; Mortishire-Smith RJ; Castro JL
Bioorg Med Chem Lett; 1999 Sep; 9(17):2491-6. PubMed ID: 10498195
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and serotonergic activity of 3-[2-(pyrrolidin-1-yl)ethyl]indoles: potent agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B receptor.
Sternfeld F; Guiblin AR; Jelley RA; Matassa VG; Reeve AJ; Hunt PA; Beer MS; Heald A; Stanton JA; Sohal B; Watt AP; Street LJ
J Med Chem; 1999 Feb; 42(4):677-90. PubMed ID: 10052975
[TBL] [Abstract][Full Text] [Related]
3. 4-Hydroxy-1-[3-(5-(1,2,4-triazol-4-yl)-1H-indol-3-yl)propyl]piperidines: selective h5-HT1D agonists for the treatment of migraine.
Bourrain S; Neduvelil JG; Beer MS; Stanton JA; Showell GA; MacLeod AM
Bioorg Med Chem Lett; 1999 Dec; 9(23):3369-74. PubMed ID: 10612601
[TBL] [Abstract][Full Text] [Related]
4. Novel potent 5-HT(1F) receptor agonists: structure-activity studies of a series of substituted N-[3-(1-methyl-4-piperidinyl)-1H-pyrrolo[3,2-b]pyridin-5-yl]amides.
Filla SA; Mathes BM; Johnson KW; Phebus LA; Cohen ML; Nelson DL; Zgombick JM; Erickson JA; Schenck KW; Wainscott DB; Branchek TA; Schaus JM
J Med Chem; 2003 Jul; 46(14):3060-71. PubMed ID: 12825944
[TBL] [Abstract][Full Text] [Related]
5. 3-(Piperazinylpropyl)indoles: selective, orally bioavailable h5-HT1D receptor agonists as potential antimigraine agents.
Chambers MS; Street LJ; Goodacre S; Hobbs SC; Hunt P; Jelley RA; Matassa VG; Reeve AJ; Sternfeld F; Beer MS; Stanton JA; Rathbone D; Watt AP; MacLeod AM
J Med Chem; 1999 Feb; 42(4):691-705. PubMed ID: 10052976
[TBL] [Abstract][Full Text] [Related]
6. Inverse agonist properties of antipsychotic agents at cloned, human (h) serotonin (5-HT)(1B) and h5-HT(1D) receptors.
Audinot V; Newman-Tancredi A; Cussac D; Millan MJ
Neuropsychopharmacology; 2001 Sep; 25(3):410-22. PubMed ID: 11522469
[TBL] [Abstract][Full Text] [Related]
7. SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors.
Price GW; Burton MJ; Collin LJ; Duckworth M; Gaster L; Göthert M; Jones BJ; Roberts C; Watson JM; Middlemiss DN
Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):312-20. PubMed ID: 9303567
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of novel 2-oxo-1,2-dihydro-3-quinolinecarboxamide derivatives as serotonin 5-HT4 receptor agonists.
Suzuki M; Ohuchi Y; Asanuma H; Kaneko T; Yokomori S; Ito C; Isobe Y; Muramatsu M
Chem Pharm Bull (Tokyo); 2000 Dec; 48(12):2003-8. PubMed ID: 11145160
[TBL] [Abstract][Full Text] [Related]
9. Benzylimidazolines as h5-HT1B/1D serotonin receptor ligands: a structure-affinity investigation.
Law H; Dukat M; Teitler M; Lee DK; Mazzocco L; Kamboj R; Rampersad V; Prisinzano T; Glennon RA
J Med Chem; 1998 Jun; 41(13):2243-51. PubMed ID: 9632357
[TBL] [Abstract][Full Text] [Related]
10. 3-[3-(Piperidin-1-yl)propyl]indoles as highly selective h5-HT(1D) receptor agonists.
Russell MG; Matassa VG; Pengilley RR; van Niel MB; Sohal B; Watt AP; Hitzel L; Beer MS; Stanton JA; Broughton HB; Castro JL
J Med Chem; 1999 Dec; 42(24):4981-5001. PubMed ID: 10585208
[TBL] [Abstract][Full Text] [Related]
11. How efficacious are 5-HT1B/D receptor ligands: an answer from GTP gamma S binding studies with stably transfected C6-glial cell lines.
Pauwels PJ; Tardif S; Palmier C; Wurch T; Colpaert FC
Neuropharmacology; 1997; 36(4-5):499-512. PubMed ID: 9225275
[TBL] [Abstract][Full Text] [Related]
12. Actions of roxindole at recombinant human dopamine D2, D3 and D4 and serotonin 5-HT1A, 5-HT1B and 5-HT1D receptors.
Newman-Tancredi A; Cussac D; Audinot V; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):447-53. PubMed ID: 10431754
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and evaluation of bicyclic benzamides as novel 5-HT1F receptor agonists.
Zhang D; Kohlman D; Krushinski J; Liang S; Ying BP; Reilly JE; Dinn SR; Wainscott DB; Nutter S; Gough W; Nelson DL; Schaus JM; Xu YC
Bioorg Med Chem Lett; 2004 Dec; 14(24):6011-6. PubMed ID: 15546719
[TBL] [Abstract][Full Text] [Related]
14. Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists.
Newman-Tancredi A; Verrièle L; Chaput C; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):205-17. PubMed ID: 9550290
[TBL] [Abstract][Full Text] [Related]
15. 5-Alkyltryptamine derivatives as highly selective and potent 5-HT1D receptor agonists.
Slassi A; Edwards L; O'Brien A; Meng CQ; Xin T; Seto C; Lee DK; MacLean N; Hynd D; Chen C; Wang H; Kamboj R; Rakhit S
Bioorg Med Chem Lett; 2000 Aug; 10(15):1707-9. PubMed ID: 10937729
[TBL] [Abstract][Full Text] [Related]
16. Constitutive activity at serotonin 5-HT(1D) receptors: detection by homologous GTPgammaS versus [(35)S]-GTPgammaS binding isotherms.
Audinot V; Newman-Tancredi A; Millan MJ
Neuropharmacology; 2001; 40(1):57-64. PubMed ID: 11077071
[TBL] [Abstract][Full Text] [Related]
17. Agonist, antagonist, and inverse agonist properties of antipsychotics at human recombinant 5-HT(1A) receptors expressed in HeLa cells.
Cosi C; Koek W
Eur J Pharmacol; 2001 Dec; 433(1):55-62. PubMed ID: 11755134
[TBL] [Abstract][Full Text] [Related]
18. Antibody capture assay reveals bell-shaped concentration-response isotherms for h5-HT(1A) receptor-mediated Galpha(i3) activation: conformational selection by high-efficacy agonists, and relationship to trafficking of receptor signaling.
Newman-Tancredi A; Cussac D; Marini L; Millan MJ
Mol Pharmacol; 2002 Sep; 62(3):590-601. PubMed ID: 12181435
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of oral absorption in selective 5-HT1D receptor agonists: fluorinated 3-[3-(piperidin-1-yl)propyl]indoles.
Castro JL; Collins I; Russell MG; Watt AP; Sohal B; Rathbone D; Beer MS; Stanton JA
J Med Chem; 1998 Jul; 41(15):2667-70. PubMed ID: 9667955
[No Abstract] [Full Text] [Related]
20. Characterization of 5-hydroxytryptamine (5-HT) receptor subtypes influencing colonic motility in conscious dogs.
Nagakura Y; Kamato T; Nishida A; Ito H; Yamano M; Miyata K
Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):489-98. PubMed ID: 8740141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
